Sirolimus (rapamycin)
Email me the evidence briefSafety
SafetySirolimus and alcohol: what actually happens if you mix themSirolimus doesn't have a classic disulfiram-type alcohol reaction, but drinking still stacks liver, immune, and mouth-ulcer risks. Here's the real data.Read guide →SafetySirolimus in older adults: what the evidence actually showsMice on rapamycin live 9-14% longer (NIA ITP data). No completed human lifespan trial exists. Here's what's real, what's hoped for, and the risks.Read guide →SafetyDoes sirolimus need to be refrigerated? Storage rulesSirolimus tablets and reconstituted vials have different rules. Here's what USP labeling, FDA data and pharmacist guidance say about heat, cold and light.Read guide →SafetyIs sirolimus safe? What the human and mouse data showSirolimus is FDA-approved for transplant use at immunosuppressive doses. For longevity, it's off-label with no completed human lifespan trial. Here's the real risk data.Read guide →SafetySirolimus and athlete drug testing: is it banned?Sirolimus isn't on WADA's Prohibited List by name, but its immunosuppressive and metabolic effects raise real questions. Here's what athletes need to know.Read guide →SafetySirolimus and blood work: which labs, and how oftenSirolimus and blood work explained: lipid panel, CBC, glucose, trough levels. What off-label users test, how often, and why the human safety data is thin.Read guide →SafetySirolimus contraindications: who should not take rapamycinSirolimus (rapamycin) is contraindicated in pregnancy, active infection, and certain lung and liver conditions. No human longevity trial exists to weigh against these risks.Read guide →SafetySirolimus drug interactions: the full safety rundownCYP3A4/P-gp interactions, grapefruit, vaccines, and the immunosuppression risk of off-label rapamycin. What actually matters, backed by FDA labeling and NIH data.Read guide →SafetySirolimus in women: what the evidence actually showsNo human lifespan trial has ever tested rapamycin in women. Here's what mouse data, transplant records, and off-label reports actually say about sex differences.Read guide →SafetySirolimus legal status: what's FDA-approved vs. off-labelSirolimus is FDA-approved for transplant rejection, not aging. Longevity dosing is 100% off-label and legal only via prescription. Here's the real regulatory picture.Read guide →SafetySirolimus long term side effects: what the data showsNo human trial has tracked low-dose rapamycin past a few years. Here's what transplant data, mouse studies, and case reports tell us about long-term risk.Read guide →SafetySirolimus side effects: what the data actually showsMouth ulcers, high cholesterol, low white cells: sirolimus's real side effect profile, drawn from transplant data, since no completed human longevity trial exists.Read guide →